Design considerations, architecture, and use of the Mini-Sentinel distributed data system-Reference-Cited by-同舟云学术

Design considerations, architecture, and use of the Mini-Sentinel distributed data system

Published:2012-01 Issue: Volume:21 Page:23-31
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Curtis Lesley H.¹,Weiner Mark G.²,Boudreau Denise M.³,Cooper William O.⁴,Daniel Gregory W.⁵,Nair Vinit P.⁶,Raebel Marsha A.⁷,Beaulieu Nicolas U.⁸,Rosofsky Robert⁹,Woodworth Tiffany S.⁸,Brown Jeffrey S.⁸

Affiliation:

1. Duke Clinical Research Institute and Department of Medicine; Duke University School of Medicine; Durham NC USA

2. Department of Medicine; University of Pennsylvania School of Medicine; Philadelphia PA USA

3. Group Health Institute; Seattle WA USA

4. Departments of Pediatrics and Preventive Medicine; Vanderbilt University Medical Center; Nashville Tennessee USA

5. HealthCore, Inc.; Wilmington DE USA

6. Humana; Louisville KY USA

7. Kaiser Permanente Colorado Institute for Health Research; Denver CO USA

8. Department of Population Medicine; Harvard Pilgrim Health Care Institute and Harvard Medical School; Boston MA USA

9. Health Information Systems Consulting LLC

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.2336/fullpdf

Reference28 articles.

1. Sliver Spring, MD: Food and Drug Administration 2008 The Sentinel Initiative: national strategy for monitoring medical product safety http://www.fda.gov/downloads/Safety/FDAsSentinelInitiative/UCM124701.pdf

2. Developing the Sentinel System-a national resource for evidence development;Behrman;N Engl J Med,2011

3. About Mini-Sentinel http://mini-sentinel.org/about_us/

4. Design of a National Distributed Health Data Network;Maro;Ann Intern Med,2009

5. Brown JS Lane K Moore K et al Defining and Evaluating Possible Database Models to Implement the FDA Sentinel Initiative; U.S. Food and Drug Administration: FDA-2009-N-0192-0005.2009 http://www.regulations.gov/search/Regs/home.html#documentDetail?R=090000648098c282

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer’s Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial;PLOS ONE;2024-02-12

2. Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States;Clinical Epidemiology;2024-02

3. Application of the US Food and Drug Administration’s Sentinel Routine Querying Tools to the Taiwan Sentinel Data Model-formatted National Health Insurance Research Database;Journal of Food and Drug Analysis;2023-12-15

4. Factors Influencing the Acceptance of Distributed Research Networks in Korea: Data Accessibility and Data Security Risk;Healthcare Informatics Research;2023-10-31

5. Six Years of the US Food and Drug Administration's Postmarket Active Risk Identification and Analysis System in the Sentinel Initiative: Implications for Real World Evidence Generation;Clinical Pharmacology & Therapeutics;2023-07-18